Literature DB >> 11922464

Ocular disposition and tolerance of ganciclovir-loaded albumin nanoparticles after intravitreal injection in rats.

Marta Merodio1, Juan Manuel Irache, Fatemeh Valamanesh, Massoud Mirshahi.   

Abstract

Cytomegalovirus (CMV) infection mainly affects endothelial cells of ocular vessels, optic nerve and the retina, resulting in direct or autoimmune damages, uveoretinitis and disturbed vision. The use of colloidal carriers for the intravitreal delivery of ganciclovir may prolong its residence in the eye, minimizing the opacification observed for macroscopic implants. The aim of this work was to evaluate the ocular toxicity induced by the prolonged presence of ganciclovir-loaded bovine serum albumin nanoparticles after their intravitreal injection. The intraocular disposition of these carriers was also studied by immunochemistry. Two weeks post-injection, a significant amount of nanoparticles remained in the vitreous cavity, mainly in a thin layer overlying the retina and in the area close to the blood aqueoUs barrier. Their prolonged residence in the eve seemed to be well tolerated and the histological evaluation of the retina, mainly the photoreceptor layer, and adjacent tissues revealed the absence of inflammatory reactions or alterations in the tissue architecture (i.e. cellular infiltrations or vascular inflammation). In addition, nanoparticles neither alter the expression and distribution of arrestin and rhodopsin autoantigens nor the mineralocorticoid receptor. In summary, the vision was not affected by autoimmune phenomena or alterations in the behavior of ophthalmic cells due to the intravitreal injection of these nanoparticles.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11922464     DOI: 10.1016/s0142-9612(01)00284-8

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  19 in total

Review 1.  New techniques for drug delivery to the posterior eye segment.

Authors:  Esther Eljarrat-Binstock; Jacob Pe'er; Abraham J Domb
Journal:  Pharm Res       Date:  2010-02-13       Impact factor: 4.200

Review 2.  Nanomedicine in the application of uveal melanoma.

Authors:  Shuo You; Jing Luo; Hans E Grossniklaus; Ma-Ling Gou; Ke Meng; Qing Zhang
Journal:  Int J Ophthalmol       Date:  2016-08-18       Impact factor: 1.779

3.  Optimization of PEGylation conditions for BSA nanoparticles using response surface methodology.

Authors:  Hasan Kouchakzadeh; Seyed Abbas Shojaosadati; Amir Maghsoudi; Ebrahim Vasheghani Farahani
Journal:  AAPS PharmSciTech       Date:  2010-08-03       Impact factor: 3.246

4.  Drug delivery to the posterior segment of the eye for pharmacologic therapy.

Authors:  Shalin S Shah; Lori Vidal Denham; Jasmine R Elison; Partha S Bhattacharjee; Christian Clement; Tashfin Huq; James M Hill
Journal:  Expert Rev Ophthalmol       Date:  2010-02-01

5.  Micelle formulation of hexadecyloxypropyl-cidofovir (HDP-CDV) as an intravitreal long-lasting delivery system.

Authors:  Feiyan Ma; Kaihui Nan; SuNa Lee; James R Beadle; Huiyuan Hou; William R Freeman; Karl Y Hostetler; Lingyun Cheng
Journal:  Eur J Pharm Biopharm       Date:  2014-12-13       Impact factor: 5.571

6.  NANOTECHNOLOGY IN THE TREATMENT AND DETECTION OF INTRAOCULAR CANCERS.

Authors:  Ashwin Nair; Paul Thevenot; Wenjing Hu; Liping Tang
Journal:  J Biomed Nanotechnol       Date:  2008-12-01       Impact factor: 4.099

7.  5-Fluorouracil-loaded BSA nanoparticles: formulation optimization and in vitro release study.

Authors:  Amir Maghsoudi; Seyed Abbas Shojaosadati; Ebrahim Vasheghani Farahani
Journal:  AAPS PharmSciTech       Date:  2008-10-11       Impact factor: 3.246

Review 8.  Nanoparticles in modern medicine: state of the art and future challenges.

Authors:  Shashi K Murthy
Journal:  Int J Nanomedicine       Date:  2007

9.  Pharmacokinetics and tolerance study of intravitreal injection of dexamethasone-loaded nanoparticles in rabbits.

Authors:  Linhua Zhang; Yue Li; Chao Zhang; Yusheng Wang; Cunxian Song
Journal:  Int J Nanomedicine       Date:  2009-09-10

10.  Hyaluronic-Coated Albumin Nanoparticles for the Non-Invasive Delivery of Apatinib in Diabetic Retinopathy.

Authors:  Salma El-Sayed Radwan; Amal El-Kamel; Eiman I Zaki; Susi Burgalassi; Erica Zucchetti; Riham M El-Moslemany
Journal:  Int J Nanomedicine       Date:  2021-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.